[1]. Balagopalan, L et al. (2010). “The LAT story: a tale of cooperativity, coordination, and choreography.” Cold Spring Harbor perspectives in biology 2(8): a005512.
[2]. Fuller, D.M. et al. (2011). “A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation, and autoimmunity.” Immunologic research 49(1-3): 97-108.
[3]. Jerome,K.R. (2008). “Viral modulation of T-cell Receptor Signaling” J. Virol 82(9): 4194-4204.
[4]. Wonerow, P, and Watson, S.P. (2001). “The transmembrane adapter LAT plays a central role in immune receptor signalling.” Oncogene 20(44): 6273-6283.
[5]. Aguado, E, and Martinez-Florensa, M. (2005). “The role of the adapter LAT in T cell activation and maturation.” J Immunol 24(2): 224–234. .
[6]. Torgersen K.M. et al. (2001). “A soluble LAT deletion mutant inhibits T-cell activation: reduced recruitment of signalling molecules to glycolipid-enriched microdomains.” Cell Signal 13:213-220
[7]. Martínez-Florensa M et al (2011). “Serine residues in the LAT adaptor are essential for TCR-dependent signal transduction.” J Leukoc Biol. 89(1):63-73
[8]. Zhang, W et al. (2000). “Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues.” The Journal of biological chemistry 275(30): 23355-23361[9]. Brdicka, T. et al. (2002). “Non-T Cell Activation Linker (NTAL): A Transmembrane Adaptor Protein Involved in Immunoreceptor Signaling.” Journal of Experimental Medicine 196(12): 1617-1626.
[9]. Brdicka, T. et al. (2002). “Non-T Cell Activation Linker (NTAL): A Transmembrane Adaptor Protein Involved in Immunoreceptor Signaling.” Journal of Experimental Medicine 196(12): 1617-1626.